Drug Trial Radar · NCT01359020
Ibuprofen, Acetaminophen and Dipyrone to Fever Control in Children
Last checked: Nov 19, 2026Latest source record: May 24, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
396
Actual
Start
Jan 2007
Primary completion
Mar 2008
Study completion Mar 2008
Sponsor
- Lead sponsor
- Mantecorp Industria Quimica e Farmaceutica Ltd.Industry
- Sponsor type
- Industry
- First posted
- May 24, 2011
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 6 months, up to 6 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study was to compare the efficacy and tolerability of acetaminophen, dipyrone and ibuprofen to fever control in children. For the efficacy asses were compared: * the time to start the action; * the action duration; * the difference between the basal temperature and the lower temperature in the study period. For the tolerability asses all adverse events were recorded, as well as your intensity and the relation to the treatment.
Conditions
- Fever
Interventions
ibuprofen, dipyrone, acetaminophenDrug
The dosage for the three drugs was the same: 10 milligrams per kilo, oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Antipyretic efficacyTime frame: Temperature was verified 15, 30, 45 and 60 minutes, 2, 3, 4, 5, 6, 7 and 8 hours after the administration of the drug.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Instituto de Medicina Integral Professor Fernando Figueira
Recife, Pernambuco, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.